Monoclonal Antibodies
Preclinical And Clinical Advances To Headline At Conference
Published in Vaccine Weekly, July 25th, 2001
Late-breaking advances in engineered antibodies research, in post-genomic high-throughput (HTP) antibody research, in development of novel targets/selection, as well as monoclonal antibody generation and preclinical and clinical advances will be the focus of the "Engineered Antibodies Accelerating Drug Discovery and Development Conference and Exposition" taking place in Philadelphia, Pennsylvania, on September 18-19, 2001.
The meeting will be divided into four discrete sections, of five to eight papers each: 1) post-genomic HTP antibody research and development, 2) novel targets and selection, 3) monoclonal antibody generation, and 4) preclinical/clinical progress. The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2001-07-25)
More Articles from Vaccine Weekly
- Adjuvants
GFP-A2/CTB Complexes Could Broaden Horizons Of Cholera Toxin-Based Vaccines - Influenza B
Revaccination Effective In Rare Cases of Hib Vaccine Failure - Asthma
M. Vaccae Immunization Fails To Stop Asthma - Breast Cancer
Vaccination With MUC1 Peptide Is Effective Against Tumors In Vitro - Chlamydia
New mAb Vaccine Protects Mice From Human C. Trachomatis Strain - Helicobacter pylori
Lactococcus Lactis Fails To Deliver Protection - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
